A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancer.

Trial Profile

A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Jan 2014

At a glance

  • Drugs Irinotecan (Primary) ; Nedaplatin (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jan 2014 Planned End Date changed from 1 Mar 2017 to 1 Dec 2016 as reported by University Hospital Medical Information Network - Japan.
    • 17 Jan 2012 Planned end date 1 Mar 2017 added as reported by University Hospital Medical Information Network - Japan.
    • 17 Jan 2012 Status changed from recruiting to active, no longer recruitingas reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top